Northwestern University ranks 10th among worldwide institutions with the most highly cited researchers in 2015. The Thomson Reuters analysis includes nine Feinberg faculty members.
Scientists showed that it is possible to specifically modify gene expression in diseased upper motor neurons in a new Northwestern Medicine translational study.
Yongchao Ma, PhD, assistant professor of Pediatrics, has received a 5-year, $1.5 million grant from the National Institute of Neurological Disorders and Stroke to explore a novel mechanism regulating mitochondria, and how it relates to motor neuron degeneration.
New insights into male germline development may help scientists better understand how external factors might have an effect on the germ cells of offspring in the future.
A phase III clinical trial including Northwestern Medicine investigator Steven Flamm, MD, tested a new combination of antiviral drugs for hepatitis C patients with late-stage cirrhosis.
The Department of Ophthalmology has received an $115,000 unrestricted grant from Research to Prevent Blindness to support research into the causes, treatment and prevention of blinding diseases.
First-year medical student Martin Mutonga was the first author of a recent paper that identified a potential drug target in acute lymphoblastic leukemia.
A recent study conducted by Feinberg postdoctoral fellow Sungshin Kim, PhD, used neuroimaging to show how motor learning unfolds in the brain over time.
A recent study led by Elizabeth Perlman, MD, discovered a new genetic mutation in the most common type of pediatric kidney cancer, Wilms tumor.
Research conducted in the laboratory of Derek Wainwright, PhD, assistant professor of Neurological Surgery, explores strategies to reverse pathways that inhibit the body’s immune system from fighting glioblastoma.